Safety and Tolerability of Metronidazole Gel 1.3%

Clinical trial NCT02392026 · COMPLETED

Trial details

NCT number: NCT02392026
Sponsor: Insud Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vaginosis, Bacterial

Start date: 2015-08-12
Primary completion: 2016-10-05
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.